These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Long-term outcomes after catheter ablation of ventricular tachycardia in patients with and without structural heart disease. Kumar S; Romero J; Mehta NK; Fujii A; Kapur S; Baldinger SH; Barbhaiya CR; Koplan BA; John RM; Epstein LM; Michaud GF; Tedrow UB; Stevenson WG Heart Rhythm; 2016 Oct; 13(10):1957-63. PubMed ID: 27392945 [TBL] [Abstract][Full Text] [Related]
4. Ablation Outcomes and Predictors of Mortality Following Catheter Ablation for Ventricular Tachycardia: Data From the German Multicenter Ablation Registry. Tilz RR; Lin T; Eckardt L; Deneke T; Andresen D; Wieneke H; Brachmann J; Kääb S; Chun KRJ; Münkler P; Lewalter T; Hochadel M; Senges J; Kuck KH J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29572321 [TBL] [Abstract][Full Text] [Related]
5. Impact of repeat ablation of ventricular tachycardia in patients with structural heart disease. Garcia Garcia J; Arya A; Dinov B; Bollmann A; Ter Bekke RMA; Vernooy K; Dagres N; Hindricks G; Darma A Europace; 2023 Dec; 26(1):. PubMed ID: 38127308 [TBL] [Abstract][Full Text] [Related]
6. Predictors of long-term mortality after catheter ablation of ventricular tachycardia in a contemporary cohort of patients with structural heart disease. Darma A; Bertagnolli L; Dinov B; Torri F; Shamloo AS; Lurz JA; Dagres N; Husser-Bollmann D; Bollmann A; Hindricks G; Arya A Europace; 2020 Nov; 22(11):1672-1679. PubMed ID: 32830252 [TBL] [Abstract][Full Text] [Related]
7. Focal Ventricular Tachycardias in Structural Heart Disease: Prevalence, Characteristics, and Clinical Outcomes After Catheter Ablation. Anderson RD; Lee G; Trivic I; Campbell T; Pham T; Nalliah C; Kizana E; Thomas SP; Trivedi SJ; Watts T; Kalman J; Kumar S JACC Clin Electrophysiol; 2020 Jan; 6(1):56-69. PubMed ID: 31971907 [TBL] [Abstract][Full Text] [Related]
8. Ventricular tachycardia arising from the aortomitral continuity in structural heart disease: characteristics and therapeutic considerations for an anatomically challenging area of origin. Steven D; Roberts-Thomson KC; Seiler J; Inada K; Tedrow UB; Mitchell RN; Sobieszczyk PS; Eisenhauer AC; Couper GS; Stevenson WG Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):660-6. PubMed ID: 20009078 [TBL] [Abstract][Full Text] [Related]
9. Prediction and prognosis of ventricular tachycardia recurrence after catheter ablation with remote magnetic navigation for electrical storm in patients with ischemic cardiomyopathy. Jin Q; Jacobsen PK; Pehrson S; Chen X Clin Cardiol; 2017 Nov; 40(11):1083-1089. PubMed ID: 28817194 [TBL] [Abstract][Full Text] [Related]
10. Clinical and Electrophysiological Characteristics of Ventricular Tachycardias From the Basal Septum in Structural Heart Disease. Kotake Y; Campbell T; Bennett RG; Turnbull S; Huang K; Ross N; Trivic I; De Silva K; Bhaskaran A; Kumar S JACC Clin Electrophysiol; 2021 Oct; 7(10):1274-1284. PubMed ID: 34454889 [TBL] [Abstract][Full Text] [Related]
11. Role of assist device implantation and heart transplantation in the long-term outcome of patients with structural heart disease after catheter ablation of ventricular tachycardia. Darma A; Bertagnolli L; Dinov B; Shamloo AS; Torri F; Efimova E; Dagres N; Husser-Bollmann D; Bollmann A; Hindricks G; Arya A Herzschrittmacherther Elektrophysiol; 2021 Sep; 32(3):353-358. PubMed ID: 34269843 [TBL] [Abstract][Full Text] [Related]
12. Catheter ablation of ventricular tachycardia and mortality in patients with nonischemic dilated cardiomyopathy: can noninducibility after ablation be a predictor for reduced mortality? Dinov B; Arya A; Schratter A; Schirripa V; Fiedler L; Sommer P; Bollmann A; Rolf S; Piorkowski C; Hindricks G Circ Arrhythm Electrophysiol; 2015 Jun; 8(3):598-605. PubMed ID: 25873719 [TBL] [Abstract][Full Text] [Related]
13. Epicardial ablation of ventricular tachycardia in patients with structural heart disease: a single-centre experience over 12 years. Darma A; Bertagnolli L; Weber A; Dinov B; Torri F; Lurz JA; Shamloo AS; Dagres N; Bollmann A; Hindricks G; Arya A Europace; 2021 Dec; 23(12):1980-1988. PubMed ID: 34405874 [TBL] [Abstract][Full Text] [Related]
15. Influence of baseline inducibility and activation mapping on ablation outcomes in patients with structural heart disease and ventricular tachycardia. Cano Ó; Pérez-Roselló V; Ayala HD; Izquierdo M; Osca J; Sancho-Tello MJ; Martínez-Dolz L J Cardiovasc Electrophysiol; 2021 May; 32(5):1328-1336. PubMed ID: 33834564 [TBL] [Abstract][Full Text] [Related]
16. Outcome of ventricular tachycardia ablation in patients with nonischemic cardiomyopathy: the impact of noninducibility. Piers SR; Leong DP; van Huls van Taxis CF; Tayyebi M; Trines SA; Pijnappels DA; Delgado V; Schalij MJ; Zeppenfeld K Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):513-21. PubMed ID: 23619893 [TBL] [Abstract][Full Text] [Related]